ebomi
Colour theme
Sign in
Insider · CIK 0001252525

Wheeler Kurt

CIK 0001252525 Name as filed on the most recent filing

Filed as Wheeler Kurt (115)

191 transaction lines · from 115 filings · filed 2004-02-23 to 2018-10-02 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

24 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2010-07-13 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 583,143, disposed Open Form 4 filing 0001012975-10-000250
2010-06-28 S, Open-market sale Senorx IncSENO 511,202, disposed Open Form 4 filing 0001209191-10-035960
2010-06-25 S, Open-market sale Senorx IncSENO 1,769,384, disposed Open Form 4 filing 0001209191-10-035960
2010-04-27 S, Open-market sale Senorx IncSENO 140,251, disposed Open Form 4 filing 0001209191-10-023995
2010-04-26 S, Open-market sale Senorx IncSENO 10,050, disposed Open Form 4 filing 0001209191-10-023995
2010-04-23 S, Open-market sale Senorx IncSENO 19,133, disposed Open Form 4 filing 0001209191-10-023679
2010-04-22 S, Open-market sale Senorx IncSENO 320,019, disposed Open Form 4 filing 0001209191-10-023679
2010-01-11 S, Open-market sale Achillion Pharmaceuticals IncACHN 881,370, disposed Open Form 4 filing 0001012975-10-000008
2010-01-07 S, Open-market sale Achillion Pharmaceuticals IncACHN 12,600, disposed Open Form 4 filing 0001012975-10-000002
2010-01-06 S, Open-market sale Achillion Pharmaceuticals IncACHN 173,033, disposed Open Form 4 filing 0001012975-10-000002
2009-12-24 S, Open-market sale Achillion Pharmaceuticals IncACHN 12,695, disposed Open Form 4 filing 0001012975-09-000362
2009-12-23 S, Open-market sale Achillion Pharmaceuticals IncACHN 981,428, disposed Open Form 4 filing 0001012975-09-000360
2009-12-21 S, Open-market sale Achillion Pharmaceuticals IncACHN 67,664, disposed Open Form 4 filing 0001012975-09-000360
2009-12-18 S, Open-market sale Achillion Pharmaceuticals IncACHN 34,650, disposed Open Form 4 filing 0001012975-09-000358
2009-12-17 S, Open-market sale Achillion Pharmaceuticals IncACHN 453,166, disposed Open Form 4 filing 0001012975-09-000358
2009-12-16 S, Open-market sale Achillion Pharmaceuticals IncACHN 242,507, disposed Open Form 4 filing 0001012975-09-000358
2009-11-09 S, Open-market sale Poniard Pharmaceuticals, Inc.PARD 1,292,442, disposed Open Form 4 filing 0001209191-09-051754
2009-11-06 S, Open-market sale Poniard Pharmaceuticals, Inc.PARD 2,132,560, disposed Open Form 4 filing 0001209191-09-051754
2009-11-05 S, Open-market sale Poniard Pharmaceuticals, Inc.PARD 626,292, disposed Open Form 4 filing 0001209191-09-051754
2009-07-08 P, Open-market purchase Somaxon Pharmaceuticals, Inc.SOMX 1,340,423, acquired Open Form 4 filing 0001209191-09-036129
2009-02-24 P, Open-market purchase EnteroMedics IncETRM 2,030,324, acquired Open Form 4 filing 0001209191-09-011453
2008-11-14 P, Open-market purchase ARYx Therapeutics, Inc.ARYX 3,932,962, acquired Open Form 4 filing 0001209191-08-061156
2008-09-08 P, Open-market purchase Achillion Pharmaceuticals IncACHN 3,791, acquired Open Form 4 filing 0001012975-08-000149
2008-09-05 P, Open-market purchase Achillion Pharmaceuticals IncACHN 6,693, acquired Open Form 4 filing 0001012975-08-000149
2008-04-16 P, Open-market purchase Metabasis Therapeutics IncMBRX 168,166, acquired Open Form 4 filing 0001209191-08-024801
2008-02-08 S, Open-market sale Pharmasset IncVRUS 146,829, disposed Open Form 4 filing 0001209191-08-009088
2008-02-07 S, Open-market sale Pharmasset IncVRUS 401,699, disposed Open Form 4 filing 0001209191-08-009088
2008-02-04 S, Open-market sale Pharmasset IncVRUS 310,013, disposed Open Form 4 filing 0001209191-08-008189
2007-11-20 P, Open-market purchase EnteroMedics IncETRM 5,000,000, acquired Open Form 4 filing 0001209191-07-065765
2007-11-13 P, Open-market purchase ARYx Therapeutics, Inc.ARYX 3,000,000, acquired Open Form 4 filing 0001209191-07-063364
2007-09-13 S, Open-market sale Hemosense IncHEM 2,235,692, disposed Open Form 4 filing 0001209191-07-053455
2007-09-12 S, Open-market sale Hemosense IncHEM 3,834,093, disposed Open Form 4 filing 0001209191-07-053455
2007-08-07 P, Open-market purchase Healthcare Acquisition CorpPIP 962,500, acquired Open Form 4 filing 0001209191-07-056847
2007-08-07 P, Open-market purchase Healthcare Acquisition CorpHAQ 962,500, acquired Open Form 4 filing 0001209191-07-046692
2007-05-30 P, Open-market purchase Helicos Biosciences CorpHLCS 2,999,997, acquired Open Form 4 filing 0001209191-07-034237
2007-05-08 S, Open-market sale Somaxon Pharmaceuticals, Inc.SOMX 1,329,317, disposed Open Form 4 filing 0001209191-07-029284
2007-05-04 S, Open-market sale Somaxon Pharmaceuticals, Inc.SOMX 68,400, disposed Open Form 4 filing 0001209191-07-028674
2007-05-02 P, Open-market purchase Pharmasset IncVRUS 2,499,993, acquired Open Form 4 filing 0001209191-07-028005
2007-05-02 S, Open-market sale Somaxon Pharmaceuticals, Inc.SOMX 12,170, disposed Open Form 4 filing 0001209191-07-027720
2007-05-01 S, Open-market sale Somaxon Pharmaceuticals, Inc.SOMX 576,968, disposed Open Form 4 filing 0001209191-07-027720
2007-04-30 S, Open-market sale Somaxon Pharmaceuticals, Inc.SOMX 352,221, disposed Open Form 4 filing 0001209191-07-026594
2007-04-30 P, Open-market purchase Poniard Pharmaceuticals, Inc.PARD 5,697,000, acquired Open Form 4 filing 0001209191-07-026597
2007-04-27 S, Open-market sale Somaxon Pharmaceuticals, Inc.SOMX 778,778, disposed Open Form 4 filing 0001209191-07-026594
2007-04-24 P, Open-market purchase Cryocor IncCRYO 496,272, acquired Open Form 4 filing 0001209191-07-025392
2005-12-20 P, Open-market purchase Somaxon Pharmaceuticals, Inc.SOMX 3,498,000, acquired Open Form 4 filing 0001209191-05-065283
2005-10-19 S, Open-market sale Cotherix IncCTRX 2,217,319, disposed Open Form 4 filing 0001209191-05-052963
2005-10-12 S, Open-market sale Cotherix IncCTRX 3,284,918, disposed Open Form 4 filing 0001209191-05-052274
2005-09-30 P, Open-market purchase Metabasis Therapeutics IncMBRX 4,100,002, disposed Open Form 4 filing 0001209191-05-050654
2005-09-07 S, Open-market sale Tercica IncTRCA 100,800, disposed Open Form 4 filing 0001209191-05-046910
2005-09-06 S, Open-market sale Tercica IncTRCA 1,179,157, disposed Open Form 4 filing 0001209191-05-046302

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
%, Ten percent owner
Ten percent owner
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 7
  • Open-market sale 17
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. WHEELER KURT, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001252525

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.